ATRA vs MAR · rev $128.9M vs P/E 32, rev $26.19B
Atara Biotherapeutics Inc (ATRA) versus Marriott International Inc (MAR) — a side-by-side from cached financials, not a winner call.
Atara Biotherapeutics Inc (ATRA) is a biotechnology company listed on NASDAQ.
Marriott International Inc (MAR) is a lodging company listed on US.
Latest reported ATRA revenue for 2024-12-31 was $128.9M. Net income was -$85.4M. Revenue was up 1404.0% from 2023-12-31 to 2024-12-31. ATRA currently screens at market cap $87.1M.
Latest reported MAR revenue for 2025-12-31 was $26.19B. Net income was $2.60B. Revenue was up 4.3% from 2024-12-31 to 2025-12-31. MAR currently screens at market cap $76.70B and trailing P/E 31.9.
ATRA currently screens at market cap $87.1M. MAR currently screens at market cap $76.70B and trailing P/E 31.9.
Not investment advice. Open the ATRA and MAR stock pages for the full models.
Not investment advice.